Abatacept Registry

Abatacept Registry

Contact

 If you are interested in participating in the study or want to learn more, please contact: Contact us
This study is now recruiting. Learn more about enrolling here.

Description
The purpose of this registry is to study the long-term effects and safety of Abatacept(Orencia) as used for the treatment of Juvenile Idiopathic Arthritis(JIA). JIA patients that are currently taking Abatacept may be eligible to participate in this study.

Eligibility and criteria
IRB Number:
17-013887
Clinical trial phase:
N/A
Official title:
An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.